Associate Director – Global Quality Management Review Lead at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Bachelor’s degree in Life Sciences, Engineering, or related field
7+ years of experience in pharmaceutical quality systems, operations, or governance
Preferred Attributes
Master’s Degree preferred
Proven experience in designing and leading management review processes in a global context
Excellent communication, leadership, and stakeholder management skills
Familiarity with digital tools such as Power BI, Tableau, SAP, and cloud platforms (AWS, Azure)
Strategic thinker with a passion for operational excellence and continuous improvement
Ability to synthesize complex information and communicate effectively to diverse audiences
Experience leading cross-functional teams and driving global initiatives

Responsibilities

Design & Implement Management Review Framework: Establish and operationalize a three-tiered management review process (site, regional, global) that aligns with corporate quality objectives
Ensure seamless integration of quality metrics across tiers for consistent visibility and decision-making
Define and maintain leading indicators and metrics aligned with strategic quality objectives
Design and deliver standardized templates and dashboards for presenting performance metrics, KPIs, trends, and strategic messages
Develop and maintain governance mechanisms to confirm adherence to review processes
Monitor effectiveness and drive continuous improvement of review cadence and content
Facilitate periodic health assessments and reviews with senior leadership
Lead the aggregation and synthesis of quality data from global sites into actionable insights
Ensure data integrity and relevance across all levels of review
Translate complex data into concise, impactful messages tailored to executive, regional, and site-level audiences
Align synthesized messages with global quality strategy and regulatory expectations
Function as a strategic liaison between Global Quality and business units (e.g., regulatory affairs, manufacturing, IT) to ensure metric relevance and adoption
Enable clear and consistent communication of quality performance and priorities
Partner with Data, Analytics & AI teams to develop intelligent quality data products
Leverage advanced analytics and visualization tools (e.g., Power BI, Tableau, SAP, AWS/Azure) to enhance reporting capabilities
Drive automation and digital transformation initiatives within the quality metrics and review space
Facilitate cross-functional collaboration to drive global corrective and preventive actions (CAPAs)
Track and report on progress of global initiatives stemming from management reviews

Skills

Quality Management

KPIs

Metrics

Dashboards

Governance

Data Aggregation

Performance Management

Regulatory Compliance

Operational Excellence

Process Improvement

Leadership

Strategic Planning

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free